Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Closed-system bioreactor optimization for bone marrow-derived human mesenchymal stem cell culture
NL-OMON41349Active, not recruiting
- Sponsor
- Xpand Biotechnology
- Start
- Nov 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of bone marrow-derived human mesenchymal stem cells, sponsored by Xpand Biotechnology. Primary endpoint: Experiments leading to optimized cell culture. Started Nov 2013; status: active, not recruiting.
02
Drugs
bone marrow-derived human mesenchymal stem cells
Beyond the preview
Go deeper on NL-OMON41349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41349.